Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001567619-22-021291

Chief Legal and HR Officer sold 6,000 shares at an average $22.79 ($136,725)

  • Chief Legal and HR Officer acquired 5,625 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Bizily Scott · Chief Legal and HR Officer

Table I: Non-derivative

11 lines
Date Transaction Shares Price Value Owned after D/I
2022-12-01 Exercise or conversion : show line 1 in the form +1,875 $6.49 $12,169 4,732 D
2022-12-01 Sale : show line 2 in the form −400 $21.52 $8,606 4,332 D
2022-12-01 Sale : show line 3 in the form −975 $22.71 $22,147 3,357 D
2022-12-01 Sale : show line 4 in the form −400 $23.25 $9,300 2,957 D
2022-12-01 Sale : show line 5 in the form −100 $24.49 $2,449 2,857 D
2022-12-01 Exercise or conversion : show line 6 in the form +3,750 $8.04 $30,150 6,607 D
2022-12-01 Sale : show line 7 in the form −1,000 $21.78 $21,775 5,607 D
2022-12-01 Sale : show line 8 in the form −2,450 $22.93 $56,180 3,157 D
Open-market sales · 6,000 sh · avg $22.79 · $136,725

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-12-01 Exercise or conversion : show line 12 in the form Stock Option (Right to Buy) −1,875 22,125 D
2022-12-01 Exercise or conversion : show line 13 in the form Stock Option (Right to Buy) −3,750 56,250 D
Loading xslF345X03/doc1.xml…